TP53 and neoplasm: To establish controlled cell platforms to assess the expression of RNF144B in TP53-dependent manner and its impact in cellular phenotypes, we used TP53 wild type non-transformed and tumour-derived lung cell lines, and their TP53-deficient derivatives.